Akero Therapeutics, Inc. (NASDAQ:AKRO) Shares Sold by Geode Capital Management LLC
otakuyassine3@gmail.com Geode Capital Management LLC reduced its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO –...
therapeutics
Fmr LLC Lowers Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)
Fmr LLC trimmed its position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report)...
Wellington Management Group LLP Boosts Stake in Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Wellington Management Group LLP boosted its stake in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA –...
ExodusPoint Capital Management LP Purchases New Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
ExodusPoint Capital Management LP acquired a new position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free...
Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)
Sei Investments Co. acquired a new position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free...
Norges Bank Acquires Shares of 110,000 Neumora Therapeutics, Inc. (NASDAQ:NMRA)
Norges Bank bought a new stake in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free...
JPMorgan Chase & Co. Has $20.51 Million Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY)
JPMorgan Chase & Co. reduced its stake in Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report)...
Arrowstreet Capital Limited Partnership Purchases 58,002 Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Arrowstreet Capital Limited Partnership lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX –...
Insider Buying: Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Acquires $10,000,000.23 in Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) Director Orbimed Advisors Llc acquired 496,771 shares...
Vanguard Group Inc. Has $330.19 Million Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Vanguard Group Inc. lowered its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by...
Needham & Company LLC Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment...